文献速递肥胖与代谢综合征糖尿病

减重较单纯运动训练更有效降低肌间脂肪与肝脏脂肪

Weight loss reduces intermuscular adipose tissue and liver fat compared to exercise: implications for muscle quality and metabolic health.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该12周随机干预研究纳入46例肥胖成人,比较减重、不减重耐力运动训练与延迟对照三组。结果显示减重使体重下降10.5%、肝脏脂肪下降33.1%、肌间脂肪体积下降12.7%,且肌间脂肪下降幅度超过骨骼肌质量下降,提示肌肉质量改善;单纯运动训练未显著改变肌间脂肪或肝脏脂肪。

要点

  • 减重可显著降低肌间脂肪体积和肝脏脂肪,并改善胰岛素敏感性。
  • 肌间脂肪下降幅度超过骨骼肌质量下降,提示肌肉质量改善。
  • 不减重耐力运动训练改善胰岛素敏感性与VO₂peak,但未显著改变肌间脂肪或肝脏脂肪。

核心结论

  • 在肥胖成人中,减重比不减重的耐力运动训练更能有效降低肌间脂肪和肝脏脂肪,且肌间脂肪的减少超过肌肉量的减少。
  • 血浆脂质和代谢物特征与肝脏脂肪及肌间脂肪体积相关,支持其作为无创生物标志物的潜在用途。

研究设计与样本

  • 采用MRI测量肌间脂肪体积、骨骼肌质量和肝脏脂肪,采用高胰岛素-正常血糖钳夹评估胰岛素敏感性,采用LC-MS进行血浆脂质组学和代谢组学分析。

主要发现

  • 减重组体重下降10.5%(P < .001),肝脏脂肪下降33.1%(P < .0001),肌间脂肪体积下降12.7%(P < .0001),胰岛素敏感性改善42%(P = .004)。
  • 减重组骨骼肌质量变化为-4.2%(P = .17),肌间脂肪下降幅度大于骨骼肌质量下降。
  • 运动训练组胰岛素敏感性改善23%(P = .04),VO₂peak增加7.6%(P < .001),但肌间脂肪和肝脏脂肪无显著变化。
  • DXA较MRI高估肌肉丢失;减重组血浆鞘脂和二酰甘油下降,运动组酰基肉碱下降。
  • 血浆三酰甘油和支链氨基酸与肝脏脂肪强相关,三酰甘油与肌间脂肪体积关联最强。

临床怎么用

  • 对肥胖成人,减重干预在降低肌间脂肪和肝脏脂肪方面可能优于单纯不减重耐力运动训练。
  • 评估肌肉质量时需注意DXA可能高估肌肉丢失,MRI测量更可靠。
  • 血浆脂质与代谢物特征有潜力作为反映肝脏脂肪和肌间脂肪的无创标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Weight loss improves insulin sensitivity and liver fat but reduces lean mass. Whether reductions in intermuscular adipose tissue (IMAT) exceed muscle loss and how these effects compare with endurance exercise training without weight loss remains unclear. OBJECTIVE: Test whether weight loss leads to greater reductions in IMAT and hepatic fat than exercise training alone, and whether these changes are reflected in plasma lipidomic and metabolomic profiles in adults with obesity. METHODS: In a 12-week randomized intervention, 46 individuals with obesity were assigned to weight loss (WL-age 39.7 ± 1.3; BMI 35.2 ± 0.9; W/M 8/9), endurance exercise training without weight loss (EX-age 39.7 ± 1.6; BMI 36.0 ± 1.1; W/M 8/8), or delayed-control intervention groups (age 39.8 ± 1.4; BMI 36.8 ± 1.3; W/M 6/7). Changes in IMAT volume, skeletal muscle mass, and liver fat measured by MRI; insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp; and plasma lipidomics and metabolomics by LC-MS based methods. RESULTS: WL reduced body weight (-10.5%; P < .001), liver steatosis (-33.1%; P < .0001), and IMAT volume (-12.7%; P < .0001), while improving insulin sensitivity (42%; P = .004). IMAT decreased significantly more than skeletal muscle mass (-4.2%, P = .17), indicating improved muscle quality. EX increased insulin sensitivity (23%; P = .04) and VO₂peak (7.6%; P < .001) but did not significantly change IMAT or liver fat. DXA overestimated muscle loss compared with MRI. WL decreased plasma sphingolipids and diacylglycerols, whereas EX reduced acylcarnitines. Plasma triacylglycerols and branched-chain amino acids were strongly correlated with liver fat, and triacylglycerols showed the strongest association with IMAT volume. CONCLUSION: Weight loss is more effective than endurance exercise training without weight loss for reducing IMAT and liver steatosis, with IMAT loss exceeding muscle loss. Plasma lipids and metabolites signatures are associated with liver fat and IMAT, supporting their potential utility as noninvasive biomarkers.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zemski Berry K, Garfield A, Macias E, et al. Weight loss reduces intermuscular adipose tissue and liver fat compared to exercise: implications for muscle quality and metabolic health. J Clin Endocrinol Metab. 2026. PMID: 41622038. doi:10.1210/clinem/dgag018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。